March 30, 2020

HHS: FDA issues emergency authorization of anti-malaria drugs for COVID-19 treatment

By: Judy Mathias

Editor's Note

The Department of Health and Human Services (HHS) announced on March 29 that the Food & Drug Administration (FDA) had issued an emergency use authorization for hydroxychloroquine and chloroquine in the treatment of COVID-19.

The FDA allowed for the drugs to be “donated to the Strategic National Stockpile to be distributed and prescribed by physicians to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.”

Sponsored Message

HHS also announced that Sandoz (Holzkirchen, Germany) donated 30 million doses of hydroxychloroquine to the stockpile and Bayer (Leverkusen, Germany) donated 1 million doses of chloroquine.


Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

OR Manager Jobs
Live chat by BoldChat